Exact Mass: 469.1373

Exact Mass Matches: 469.1373

Found 276 metabolites which its exact mass value is equals to given mass value 469.1373, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Indol-3-ylacetyl-myo-inositol L-arabinoside

[(2S,3S,5R,6R)-2,3,5,6-tetrahydroxy-4-[(2S,3R,4S,5S)-3,4,5-trihydroxytetrahydropyran-2-yl]oxy-cyclohexyl] 2-(1H-indol-3-yl)acetate

C21H27NO11 (469.1584)

Kalbreclasine

C20H23NO12 (469.122)

RO4929097

C22H20F5N3O3 (469.1425)

D004791 - Enzyme Inhibitors > D000091062 - Gamma Secretase Inhibitors and Modulators C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

O-Methyl-4-[(2',3',4'-tri-O-acetyl-alpha-L-rhamnosyloxy)benzyl]thiocarbamate

(2S,3S,4R,5R,6S)-4,5-bis(acetyloxy)-6-(4-{[(methoxymethanethioyl)amino]methyl}phenoxy)-2-methyloxan-3-yl acetate

C21H27NO9S (469.1406)

O-Methyl-4-[(2,3,4-tri-O-acetyl-alpha-L-rhamnosyloxy)benzyl]thiocarbamate is a fully acetylated thiocarbamate glycoside. It has been isolated from the leaves of Moringa oleifera (horseradish tree). It is found in fats and oils, herbs and spices, and green vegetables. The trans and cis rotamers differ in the orientation of the NH group with respect to sulfur.

N-(2-(3-(Piperazin-1-ylmethyl)imidazo[2,1-b]thiazol-6-yl)phenyl)quinoxaline-2-carboxamide

N-{2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl}quinoxaline-2-carboximidic acid

C25H23N7OS (469.1685)

SRT 1720 is a selective activator of human SIRT1 with an EC1.5 of 0.16 μM, and shows less potent activities for SIRT2 and SIRT3 with EC1.5s of 37 μM and > 300 μM, respectively.

Bucladesine

[6-[6-(Butanoylamino)purin-9-yl]-2-hydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-D][1,3,2]dioxaphosphinin-7-yl] butanoic acid

C18H24N5O8P (469.1362)

Dacomitinib

N-{4-[(3-chloro-4-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}-4-(piperidin-1-yl)but-2-enimidate

C24H25ClFN5O2 (469.1681)

Ethanol and folate

2-[(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}phenyl)formamido]-5-ethoxy-5-oxopentanoic acid

C21H23N7O6 (469.171)

Oxaprozin glucuronide

6-{[3-(4,5-diphenyl-1,3-oxazol-2-yl)propanoyl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C24H23NO9 (469.1373)

RO4929097

N-{9-hydroxy-8-azatricyclo[9.4.0.0,]pentadeca-1(15),2,4,6,8,11,13-heptaen-10-yl}-2,2-dimethyl-N-(2,2,3,3,3-pentafluoropropyl)propanediimidate

C22H20F5N3O3 (469.1425)

D004791 - Enzyme Inhibitors > D000091062 - Gamma Secretase Inhibitors and Modulators

2-[1-[4,5-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]indol-3-yl]acetic acid

C21H27NO11 (469.1584)

ACon1_000074

C24H27N3O7 (469.1849)

Rhizocarpic acid

C28H23NO6 (469.1525)

MMV676186

C26H19N3O6 (469.1274)

O-methyl-4-<(2,3,4-tri-O-acetyl-alpha-L-rhamnopyranosyloxy)benzyl>thiocarbamate (E)|O-methyl-4-<(2,3,4-tri-O-acetyl-alpha-L-rhamnopyranosyloxy)benzyl>thiocarbamate (Z)|O-methyl-4-[(2,3,4-tri-O-acetyl-alpha-L-rhamnopyranosyloxy)benzyl]thiocarbamate (E)|O-methyl-4-[(2,3,4-tri-O-acetyl-alpha-L-rhamnopyranosyloxy)benzyl]thiocarbamate (Z)

O-methyl-4-<(2,3,4-tri-O-acetyl-alpha-L-rhamnopyranosyloxy)benzyl>thiocarbamate (E)|O-methyl-4-<(2,3,4-tri-O-acetyl-alpha-L-rhamnopyranosyloxy)benzyl>thiocarbamate (Z)|O-methyl-4-[(2,3,4-tri-O-acetyl-alpha-L-rhamnopyranosyloxy)benzyl]thiocarbamate (E)|O-methyl-4-[(2,3,4-tri-O-acetyl-alpha-L-rhamnopyranosyloxy)benzyl]thiocarbamate (Z)

C21H27NO9S (469.1406)

C28H23NO6

C28H23NO6 (469.1525)

fumiquinazoline K

C26H23N5O4 (469.175)

C25H27NO8

C25H27NO8 (469.1737)

N12-5(S)-N13-1(R)-L-rhamnosylarcyriaflavin

C26H19N3O6 (469.1274)

Narciclasine 4-O-glucoside

C20H23NO12 (469.122)

5-O-beta-D-glucopyranosyl-dihydroABG|5-O-beta-D-glucopyranosyl-dihydroascorbigen

C21H27NO11 (469.1584)

narciclasine-4-O-beta-D-glucopyranoside

C20H23NO12 (469.122)

C15H27N5O12

C15H27N5O12 (469.1656)

Bucladesine

[(4aR,7R,7aR)-6-[6-(butanoylamino)purin-9-yl]-2-hydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-yl] butanoate

C18H24N5O8P (469.1362)

C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CE - Phosphodiesterase inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor

SRT 1720

N-(2-(3-(piperazin-1-ylmethyl)imidazo[2,1-b]thiazol-6-yl)phenyl)quinoxaline-2-carboxamide

C25H23N7OS (469.1685)

SRT 1720 is a selective activator of human SIRT1 with an EC1.5 of 0.16 μM, and shows less potent activities for SIRT2 and SIRT3 with EC1.5s of 37 μM and > 300 μM, respectively.

CAY10589

2-[[4-[([1,1-biphenyl]-4-ylmethyl)amino]-6-chloro-2-pyrimidinyl]thio]-octanoic acid

C25H28ClN3O2S (469.1591)

(indol-3-yl)acetyl-myo-inositol L-arabinoside

C21H27NO11 (469.1584)

C21H27NO11

NCGC00380387-01_C21H27NO11_

C21H27NO11 (469.1584)

C24H27N3O7_Prolinamide, N-(4-hydroxybenzoyl)valyl-N-(2-carboxy-6-hydroxyphenyl)

NCGC00168819-02_C24H27N3O7_Prolinamide, N-(4-hydroxybenzoyl)valyl-N-(2-carboxy-6-hydroxyphenyl)-

C24H27N3O7 (469.1849)

3-hydroxy-2-[[1-[2-[(4-hydroxybenzoyl)amino]-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]benzoic acid

C24H27N3O7 (469.1849)

Ala Cys Asn Tyr

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C19H27N5O7S (469.1631)

Ala Cys Tyr Asn

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanoic acid

C19H27N5O7S (469.1631)

Ala Asn Cys Tyr

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C19H27N5O7S (469.1631)

Ala Asn Tyr Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanoic acid

C19H27N5O7S (469.1631)

Ala Tyr Cys Asn

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C19H27N5O7S (469.1631)

Ala Tyr Asn Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C19H27N5O7S (469.1631)

Cys Ala Asn Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C19H27N5O7S (469.1631)

Cys Ala Tyr Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanoic acid

C19H27N5O7S (469.1631)

Cys Cys Met Asn

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-carbamoylpropanoic acid

C15H27N5O6S3 (469.1123)

Cys Cys Asn Met

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]-4-(methylsulfanyl)butanoic acid

C15H27N5O6S3 (469.1123)

Cys Phe Asn Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C19H27N5O7S (469.1631)

Cys Phe Ser Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C19H27N5O7S (469.1631)

Cys Gly Gln Tyr

(2S)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-4-carbamoylbutanamido]-3-(4-hydroxyphenyl)propanoic acid

C19H27N5O7S (469.1631)

Cys Gly Tyr Gln

(2S)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-(4-hydroxyphenyl)propanamido]-4-carbamoylbutanoic acid

C19H27N5O7S (469.1631)

Cys His Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C18H27N7O6S (469.1743)

Cys His Pro Asn

(2S)-2-{[(2S)-1-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C18H27N7O6S (469.1743)

Cys Met Cys Asn

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C15H27N5O6S3 (469.1123)

Cys Met Asn Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C15H27N5O6S3 (469.1123)

Cys Asn Ala Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]propanamido]-3-(4-hydroxyphenyl)propanoic acid

C19H27N5O7S (469.1631)

Cys Asn Cys Met

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C15H27N5O6S3 (469.1123)

Cys Asn Phe Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-phenylpropanamido]-3-hydroxypropanoic acid

C19H27N5O7S (469.1631)

Cys Asn His Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidine-2-carboxylic acid

C18H27N7O6S (469.1743)

Cys Asn Met Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C15H27N5O6S3 (469.1123)

Cys Asn Pro His

(2S)-2-{[(2S)-1-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-(1H-imidazol-4-yl)propanoic acid

C18H27N7O6S (469.1743)

Cys Asn Ser Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-phenylpropanoic acid

C19H27N5O7S (469.1631)

Cys Asn Tyr Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanamido]propanoic acid

C19H27N5O7S (469.1631)

Cys Pro His Asn

(2S)-2-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanoic acid

C18H27N7O6S (469.1743)

Cys Pro Asn His

(2S)-2-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H27N7O6S (469.1743)

Cys Gln Gly Tyr

(2S)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]acetamido}-3-(4-hydroxyphenyl)propanoic acid

C19H27N5O7S (469.1631)

Cys Gln Tyr Gly

2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-(4-hydroxyphenyl)propanamido]acetic acid

C19H27N5O7S (469.1631)

Cys Ser Phe Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-phenylpropanamido]-3-carbamoylpropanoic acid

C19H27N5O7S (469.1631)

Cys Ser Asn Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-phenylpropanoic acid

C19H27N5O7S (469.1631)

Cys Tyr Ala Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanamido]propanamido]-3-carbamoylpropanoic acid

C19H27N5O7S (469.1631)

Cys Tyr Gly Gln

(2S)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanamido]acetamido}-4-carbamoylbutanoic acid

C19H27N5O7S (469.1631)

Cys Tyr Asn Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanamido]propanoic acid

C19H27N5O7S (469.1631)

Cys Tyr Gln Gly

2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanamido]-4-carbamoylbutanamido]acetic acid

C19H27N5O7S (469.1631)

Phe Cys Asn Ser

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C19H27N5O7S (469.1631)

Phe Cys Ser Asn

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C19H27N5O7S (469.1631)

Phe Asn Cys Ser

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C19H27N5O7S (469.1631)

Phe Asn Ser Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C19H27N5O7S (469.1631)

Phe Ser Cys Asn

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C19H27N5O7S (469.1631)

Phe Ser Asn Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C19H27N5O7S (469.1631)

Gly Cys Gln Tyr

(2S)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-(4-hydroxyphenyl)propanoic acid

C19H27N5O7S (469.1631)

Gly Cys Tyr Gln

(2S)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanamido]-4-carbamoylbutanoic acid

C19H27N5O7S (469.1631)

Gly Gln Cys Tyr

(2S)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C19H27N5O7S (469.1631)

Gly Gln Tyr Cys

(2R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanoic acid

C19H27N5O7S (469.1631)

N1-Demethylnicergoline

(8-beta)-10-Methoxy-6-methylergoline-8-methanol 5-bromo-3-pyridinecarboxylate

C23H24BrN3O3 (469.1001)

Gly Tyr Cys Gln

(2S)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C19H27N5O7S (469.1631)

Gly Tyr Gln Cys

(2R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(4-hydroxyphenyl)propanamido]-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

C19H27N5O7S (469.1631)

His Cys Asn Pro

(2S)-1-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C18H27N7O6S (469.1743)

His Cys Pro Asn

(2S)-2-{[(2S)-1-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C18H27N7O6S (469.1743)

His Asn Cys Pro

(2S)-1-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C18H27N7O6S (469.1743)

His Asn Pro Cys

(2R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C18H27N7O6S (469.1743)

His Pro Cys Asn

(2S)-2-[(2R)-2-{[(2S)-1-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C18H27N7O6S (469.1743)

His Pro Asn Cys

(2R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C18H27N7O6S (469.1743)

Met Cys Cys Asn

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C15H27N5O6S3 (469.1123)

Met Cys Asn Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C15H27N5O6S3 (469.1123)

Met Asn Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C15H27N5O6S3 (469.1123)

Asn Ala Cys Tyr

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C19H27N5O7S (469.1631)

Asn Ala Tyr Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanoic acid

C19H27N5O7S (469.1631)

Asn Cys Ala Tyr

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]propanamido]-3-(4-hydroxyphenyl)propanoic acid

C19H27N5O7S (469.1631)

Asn Cys Cys Met

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C15H27N5O6S3 (469.1123)

Asn Cys Phe Ser

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-phenylpropanamido]-3-hydroxypropanoic acid

C19H27N5O7S (469.1631)

Asn Cys His Pro

(2S)-1-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidine-2-carboxylic acid

C18H27N7O6S (469.1743)

Asn Cys Met Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C15H27N5O6S3 (469.1123)

Asn Cys Pro His

(2S)-2-{[(2S)-1-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-(1H-imidazol-4-yl)propanoic acid

C18H27N7O6S (469.1743)

Asn Cys Ser Phe

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-phenylpropanoic acid

C19H27N5O7S (469.1631)

Asn Cys Tyr Ala

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanamido]propanoic acid

C19H27N5O7S (469.1631)

Asn Phe Cys Ser

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-phenylpropanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C19H27N5O7S (469.1631)

Asn Phe Ser Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-phenylpropanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C19H27N5O7S (469.1631)

Asn His Cys Pro

(2S)-1-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C18H27N7O6S (469.1743)

Asn His Pro Cys

(2R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C18H27N7O6S (469.1743)

Asn Met Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C15H27N5O6S3 (469.1123)

Asn Pro Cys His

(2S)-2-[(2R)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H27N7O6S (469.1743)

Asn Pro His Cys

(2R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C18H27N7O6S (469.1743)

Asn Ser Cys Phe

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-phenylpropanoic acid

C19H27N5O7S (469.1631)

Asn Ser Phe Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-phenylpropanamido]-3-sulfanylpropanoic acid

C19H27N5O7S (469.1631)

Asn Ser Ser Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]-3-(4-hydroxyphenyl)propanoic acid

C19H27N5O9 (469.1809)

Asn Ser Tyr Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-(4-hydroxyphenyl)propanamido]-3-hydroxypropanoic acid

C19H27N5O9 (469.1809)

Asn Tyr Ala Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanamido]propanamido]-3-sulfanylpropanoic acid

C19H27N5O7S (469.1631)

Asn Tyr Cys Ala

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanamido]propanoic acid

C19H27N5O7S (469.1631)

Asn Tyr Ser Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C19H27N5O9 (469.1809)

Pro Cys His Asn

(2S)-3-carbamoyl-2-[(2S)-3-(1H-imidazol-4-yl)-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]propanamido]propanoic acid

C18H27N7O6S (469.1743)

Pro Cys Asn His

(2S)-2-[(2S)-3-carbamoyl-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H27N7O6S (469.1743)

Pro His Cys Asn

(2S)-3-carbamoyl-2-[(2R)-2-[(2S)-3-(1H-imidazol-4-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-sulfanylpropanamido]propanoic acid

C18H27N7O6S (469.1743)

Pro His Asn Cys

(2R)-2-[(2S)-3-carbamoyl-2-[(2S)-3-(1H-imidazol-4-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]-3-sulfanylpropanoic acid

C18H27N7O6S (469.1743)

Pro Asn Cys His

(2S)-2-[(2R)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H27N7O6S (469.1743)

Pro Asn His Cys

(2R)-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C18H27N7O6S (469.1743)

Gln Cys Gly Tyr

(2S)-2-{2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]acetamido}-3-(4-hydroxyphenyl)propanoic acid

C19H27N5O7S (469.1631)

Gln Cys Tyr Gly

2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanamido]acetic acid

C19H27N5O7S (469.1631)

Gln Gly Cys Tyr

(2S)-2-[(2R)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C19H27N5O7S (469.1631)

Gln Gly Tyr Cys

(2R)-2-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanoic acid

C19H27N5O7S (469.1631)

Gln Tyr Cys Gly

2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanamido]acetic acid

C19H27N5O7S (469.1631)

Gln Tyr Gly Cys

(2R)-2-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(4-hydroxyphenyl)propanamido]acetamido}-3-sulfanylpropanoic acid

C19H27N5O7S (469.1631)

Ser Cys Phe Asn

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-phenylpropanamido]-3-carbamoylpropanoic acid

C19H27N5O7S (469.1631)

Ser Cys Asn Phe

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-phenylpropanoic acid

C19H27N5O7S (469.1631)

Ser Phe Cys Asn

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-phenylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C19H27N5O7S (469.1631)

Ser Phe Asn Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-phenylpropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C19H27N5O7S (469.1631)

Ser Asn Cys Phe

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-phenylpropanoic acid

C19H27N5O7S (469.1631)

Ser Asn Phe Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-phenylpropanamido]-3-sulfanylpropanoic acid

C19H27N5O7S (469.1631)

Ser Asn Ser Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-(4-hydroxyphenyl)propanoic acid

C19H27N5O9 (469.1809)

Ser Asn Tyr Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-hydroxypropanoic acid

C19H27N5O9 (469.1809)

Ser Ser Asn Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C19H27N5O9 (469.1809)

Ser Ser Tyr Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanoic acid

C19H27N5O9 (469.1809)

Ser Tyr Asn Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C19H27N5O9 (469.1809)

Ser Tyr Ser Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(4-hydroxyphenyl)propanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C19H27N5O9 (469.1809)

Tyr Ala Cys Asn

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]propanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C19H27N5O7S (469.1631)

Tyr Ala Asn Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]propanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C19H27N5O7S (469.1631)

Tyr Cys Ala Asn

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanamido]propanamido]-3-carbamoylpropanoic acid

C19H27N5O7S (469.1631)

Tyr Cys Gly Gln

(2S)-2-{2-[(2R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanamido]acetamido}-4-carbamoylbutanoic acid

C19H27N5O7S (469.1631)

Tyr Cys Asn Ala

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]propanoic acid

C19H27N5O7S (469.1631)

Tyr Cys Gln Gly

2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanamido]-4-carbamoylbutanamido]acetic acid

C19H27N5O7S (469.1631)

Tyr Gly Cys Gln

(2S)-2-[(2R)-2-{2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]acetamido}-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C19H27N5O7S (469.1631)

Tyr Gly Gln Cys

(2R)-2-[(2S)-2-{2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]acetamido}-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

C19H27N5O7S (469.1631)

Tyr Asn Ala Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanamido]propanamido]-3-sulfanylpropanoic acid

C19H27N5O7S (469.1631)

Tyr Asn Cys Ala

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]propanoic acid

C19H27N5O7S (469.1631)

Tyr Asn Ser Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C19H27N5O9 (469.1809)

Tyr Gln Cys Gly

2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-4-carbamoylbutanamido]-3-sulfanylpropanamido]acetic acid

C19H27N5O7S (469.1631)

Tyr Gln Gly Cys

(2R)-2-{2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-4-carbamoylbutanamido]acetamido}-3-sulfanylpropanoic acid

C19H27N5O7S (469.1631)

Tyr Ser Asn Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C19H27N5O9 (469.1809)

Tyr Ser Ser Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C19H27N5O9 (469.1809)

N-(4-Hydroxybenzoyl)valyl-N-(2-carboxy-6-hydroxyphenyl)prolinamide

C24H27N3O7 (469.1849)

Erbulozole

C24H27N3O5S (469.1671)

ndepap

C22H24BrN5O2 (469.1113)

3-(2-BROMO-2-ETHOXYCARBONYL-VINYL)-2-PHENYL-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C24H24BrNO4 (469.0889)

Belotecan hydrochloride

Belotecan hydrochloride(CKD-602)

C25H28ClN3O4 (469.1768)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059004 - Topoisomerase I Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor D004791 - Enzyme Inhibitors

1-[2-[[4-[(2-chloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]pyridinium acetate

C23H24ClN5O4 (469.1517)

b-D-Galactopyranoside,4-nitrophenyl, 2,3,4,6-tetraacetate

C20H23NO12 (469.122)

Dacomitinib

Dacomitinib (PF299804, PF299)

C24H25ClFN5O2 (469.1681)

L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

fmoc-(s)-3-amino-4-(2-trifluoromethyl-phenyl)-butyric acid

C26H22F3NO4 (469.1501)

BENZENE, 1,1-[(4-NITROPHENYL)METHYLENE]BIS[2,4,6-TRIMETHOXY]-

C25H27NO8 (469.1737)

10-formylfolic acid (25 mg)

C20H19N7O7 (469.1346)

2-Nitrophenyl2,3-di-O-acetyl-4-O-triethylsilyl-b-D-xylopyranoside

C21H31NO9Si (469.1768)

Fmoc-(S)-3-Amino-4-(4-trifluoromethylphenyl)-butyric acid

C26H22F3NO4 (469.1501)

Fmoc-(R)-3-Amino-4-(2-trifluoromethylphenyl)-butyric acid

C26H22F3NO4 (469.1501)

Fmoc-(R)-3-Amino-4-(4-trifluoromethyl-phenyl)-butyric acid

C26H22F3NO4 (469.1501)

Fmoc-(S)-3-Amino-4-(3-trifluoromethylphenyl)-butyric acid

C26H22F3NO4 (469.1501)

(6R)-3,8-dioxo-7t-(2-phenyl-acetylamino)-(6rH)-5-thia-1-aza-bicyclo[4.2.0]octane-2ξ-carboxylic acid 4-nitro-benzyl ester

C22H19N3O7S (469.0944)

(4-METHYL-THIAZOL-2-YL)-PHENYL-AMINE

C20H23NO12 (469.122)

a-D-Galactopyranoside,4-nitrophenyl, 2,3,4,6-tetraacetate

C20H23NO12 (469.122)

benzylpenicillin β-diethylaminoethyl ester hydrochloride

C22H32ClN3O4S (469.1802)

Baricitinib phosphate

C16H20N7O6PS (469.0933)

4-nitrophenyl tetra-o-acetyl-beta-d-glucopyranoside

C20H23NO12 (469.122)

Gandotinib

C23H25ClFN7O (469.1793)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

(2R,3S,4R,5R)-2-(hydroxyMethyl)-5-(6-((2-(Methylthio)ethyl)aMino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-3,4-diol

C16H22F3N5O4S2 (469.1065)

FMOC aminotriacid

C25H27NO8 (469.1737)

Fmoc-(R)-3-Amino-4-(3-trifluoromethylphenyl)-butyric acid

C26H22F3NO4 (469.1501)

2-(2-phenyl-9H-carbazol-9-yl)dibenzo[b,d]thiophen-4-ylboronic acid

C30H20BNO2S (469.1308)

D-Glucopyranose, 2-azido-2-deoxy-3,4-bis-O-(phenylMethyl)-, 1,6-diacetate

C24H27N3O7 (469.1849)

4-[(4-Chlorophenyl)-2-pyridylmethoxy]piperidine p-nitrobenzoic acid salt

C24H24ClN3O5 (469.1404)

Ki8751

N-(2,4-Difluorophenyl)-N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]-2-fluorophenyl]urea

C24H18F3N3O4 (469.1249)

Voruciclib

C22H19ClF3NO5 (469.0904)

C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents

(E)-N-(4-(3-(tert-Butyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxystyryl)phenyl)methanesulfonamide

C24H27N3O5S (469.1671)

11c-Omar

C23H21Cl2N5O2 (469.1072)

Mycophenolate mofetil hydrochloride

C23H32ClNO7 (469.1867)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents C471 - Enzyme Inhibitor > C2087 - Inosine Monophosphate Dehydrogenase Inhibitor C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors

Sofpironium bromide

C22H32BrNO5 (469.1464)

C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent Sofpironium bromide (BBI 4000) is an anticholinergic agent used in the study of primary axillary hyperhidrosis (PAH). Sofpironium bromide reduces sweating by inhibiting M3 muscarinic receptors in eccrine glands at the application site. Sofpironium bromide also has a high afnity for the M1, M2, M4 and M5 subtypes[1].

Tryptamine guanosine carbamate

C21H23N7O6 (469.171)

CID 54733074

L-Phenylalanine, N-((3-hydroxy-5-oxo-4-phenyl-2(5H)-furanylidene)phenylacetyl)-, methyl ester

C28H23NO6 (469.1525)

Awl-II-38.3

C23H18F3N5O3 (469.1362)

3-fluoro-N-[4-[[4-(4-methoxyphenyl)-1-piperazinyl]-oxomethyl]phenyl]benzenesulfonamide

C24H24FN3O4S (469.1471)

3-(4-{2-[2-(2-Bromo-acetylamino)-ethyldisulfanyl]-ethylcarbamoyl}-cyclohexylcarbamoyl)-pyrazine-2-carboxylic acid

C19H27N5O5S2 (469.1454)

(4as,4br,10bs,12as)-12a-Methyl-1,3-Dioxo-2-(Pyridin-3-Ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-Dodecahydronaphtho[2,1-F]isoquinolin-8-Yl Sulfamate

C24H27N3O5S (469.1671)

(2s,4s,5r)-2-Isobutyl-5-(2-Thienyl)-1-[4-(Trifluoromethyl)benzoyl]pyrrolidine-2,4-Dicarboxylic Acid

C22H22F3NO5S (469.1171)

Methyl 2-[3-methoxy-2-[(5-phenyl-1,2-oxazole-3-carbonyl)amino]phenyl]-1,3-benzoxazole-4-carboxylate

C26H19N3O6 (469.1274)

2-[(4-{[([1,1-Biphenyl]-4-yl)methyl]amino}-6-chloropyrimidin-2-yl)sulfanyl]octanoic acid

C25H28ClN3O2S (469.1591)

10-Formyldihydrofolate(2-)

C20H19N7O7-2 (469.1346)

(2S)-2-[[[4-[(2-amino-4-oxo-3H-quinazolin-6-yl)methyl-formylamino]phenyl]-hydroxymethyl]amino]pentanedioic acid

C22H23N5O7 (469.1597)

Ethanol and folate

C21H23N7O6 (469.171)

6-[3-(4,5-Diphenyl-1,3-oxazol-2-yl)propanoyloxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C24H23NO9 (469.1373)

2-(4-Nitrophenoxy)-1-[4-(4-phenylphthalazin-1-yl)piperazin-1-yl]ethanone

C26H23N5O4 (469.175)

(indol-3-ylacetyl)-myo-inositol 3-L-arabinoside

C21H27NO11 (469.1584)

[5-(4-Fluorophenyl)-7-(trifluoromethyl)-2-pyrazolo[1,5-a]pyrimidinyl]-[2-(3-pyridinyl)-1-piperidinyl]methanone

C24H19F4N5O (469.1526)

3-methyl-2-[(4-methylphenyl)sulfonylamino]pentanoic acid (4-oxo-2,3-dihydro-1H-cyclopenta[c][1]benzopyran-7-yl) ester

C25H27NO6S (469.1559)

(4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-7-yl) 4-methyl-2-[(4-methylphenyl)sulfonylamino]pentanoate

C25H27NO6S (469.1559)

[2-(2-Methylpropylcarbamoylamino)-2-oxoethyl] 3-[(3,4-difluorophenyl)sulfonylamino]benzoate

C20H21F2N3O6S (469.1119)

N-(3-Methoxy-pyrazin-2-yl)-4-[3-(3-phenyl-acryloyl)-thioureido]-benzenesulfonamide

C21H19N5O4S2 (469.0878)

3-{[4-(4-methoxyphenyl)piperazin-1-yl]carbonyl}benzimidazo[1,2-c]quinazoline-6(5H)-thione

C26H23N5O2S (469.1572)

7-(4-chlorophenyl)-4-(2-fluorophenyl)-2-methyl-5-oxo-4,6,7,8-tetrahydro-1H-quinoline-3-carboxylic acid 2-methoxyethyl ester

C26H25ClFNO4 (469.1456)

1,3-bis(2-deoxy-beta-D-erythro-pentofuranosyl)-5-amino-5-methyl-6-{2-oxo-1,3-diazabicyclo[2.2.0]hex-4-en-6-yl}-1,3-diazinane-2,4-dione

C19H27N5O9 (469.1809)

An N-glycosyl compound that is a metabolite produced by the bacterium Mycoplasma genitalium.

10-(2-Amino-ethylamino)-9-(3-chloro-phenyl)-2,2,5-trimethyl-1,4-dihydro-2H,9H-3-oxa-7-thia-6,9,11-tria za-benzo[c]fluoren-8-one

C23H24ClN5O2S (469.1339)

N-(2-fluorophenyl)-2-[[7-(2-fluorophenyl)-1,3-dimethyl-2,4-dioxo-5-pyrimido[4,5-d]pyrimidinyl]thio]acetamide

C22H17F2N5O3S (469.102)

6-amino-1,3-bis(2-deoxy-beta-D-erythro-pentofuranosyl)-5-hydroxy-5-methyl-3,4-dihydro[4,4-bipyrimidine]-2,2(1H,3H)-dione

C19H27N5O9 (469.1809)

An N-glycosyl compound that is a metabolite produced by the bacterium Mycoplasma genitalium.

2-Deoxycytidine-thymidine

C19H27N5O9 (469.1809)

dihydroascorbigen 5-O-beta-D-glucoside

C21H27NO11 (469.1584)

A dihydroascorbigen hexoside in which the hexoside component is a beta-D-glucosyl residue attached at position 5 via a glycosidic bond.

N-(2,6-dimethoxy-4-pyrimidinyl)-4-[(4-phenyl-2-thiazolyl)amino]benzenesulfonamide

C21H19N5O4S2 (469.0878)

butanoic acid [(4aS,5R,6R,7aR)-2-hydroxy-2-oxo-6-[6-(1-oxobutylamino)-9-purinyl]-4a,5,6,7a-tetrahydro-4H-furo[2,3-d][1,3,2]dioxaphosphorin-5-yl] ester

C18H24N5O8P (469.1362)

Flucloxacilloyl

C20H21ClFN3O5S (469.0874)

Perquinoline A

C24H27N3O7 (469.1849)

1-[(1S)-1-[(4-chlorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone

C25H28ClN3O4 (469.1768)

1-[(1R)-1-[(4-chlorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone

C25H28ClN3O4 (469.1768)

1-[(1S)-2-[(3-chlorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone

C25H28ClN3O4 (469.1768)

1-[(1R)-1-(benzenesulfonyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]ethanone

C24H27N3O5S (469.1671)

2-methoxyethyl (4S,7S)-7-(4-chlorophenyl)-4-(2-fluorophenyl)-2-methyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate

C26H25ClFNO4 (469.1456)

6-amino-N-{4-[(3-chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxyquinolin-6-yl}hexanamide

C24H25ClFN5O2 (469.1681)

methyl (2S)-2-[[(2Z)-2-(3,5-dioxo-4-phenyloxolan-2-ylidene)-2-phenylacetyl]amino]-3-phenylpropanoate

C28H23NO6 (469.1525)

[(4aR,5R,6R,7aR)-6-[6-(butanoylamino)purin-9-yl]-2-hydroxy-2-oxo-4a,5,6,7a-tetrahydro-4H-furo[2,3-d][1,3,2]dioxaphosphinin-5-yl] butanoate

C18H24N5O8P (469.1362)

butanoic acid [(4aS,6S,7S,7aS)-2-hydroxy-2-oxo-6-[6-(1-oxobutylamino)-9-purinyl]-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphorin-7-yl] ester

C18H24N5O8P (469.1362)

2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[2-(hydroxymethyl)-3-oxo-1-phenylpropyl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid

C20H27N3O8S (469.1519)

2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[1-(3-hydroxyphenyl)-2-methyl-3-oxopropyl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid

C20H27N3O8S (469.1519)

2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2-hydroxy-3-oxo-1-phenylbutyl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid

C20H27N3O8S (469.1519)

(2S)-2-azaniumyl-5-{[(2R)-1-[(carboxylatomethyl)amino]-1-oxo-3-{[(2-phenylethyl)carbamothioyl]sulfanyl}propan-2-yl]amino}-5-oxopentanoate

C19H25N4O6S2- (469.1215)

oxolan-2-ylmethyl 4-(6-chloro-4-oxochromen-3-yl)-2-methyl-5-oxo-4a,6,7,8-tetrahydro-4H-quinoline-3-carboxylate

C25H24ClNO6 (469.1292)

2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[1-(4-hydroxyphenyl)-2-methyl-3-oxopropyl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid

C20H27N3O8S (469.1519)

2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2-hydroxy-2-methyl-3-oxo-1-phenylpropyl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid

C20H27N3O8S (469.1519)

2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(1-hydroxy-2-methyl-3-oxo-1-phenylpropan-2-yl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid

C20H27N3O8S (469.1519)

2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[1-(2-hydroxyphenyl)-2-methyl-3-oxopropyl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid

C20H27N3O8S (469.1519)

2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(1-hydroxy-3-oxo-1-phenylbutan-2-yl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid

C20H27N3O8S (469.1519)

2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[1-(4-methoxyphenyl)-3-oxopropyl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid

C20H27N3O8S (469.1519)

[(2S,3S,5R,6R)-2,3,5,6-tetrahydroxy-4-[(2S,3R,4S,5S)-3,4,5-trihydroxytetrahydropyran-2-yl]oxy-cyclohexyl] 2-(1H-indol-3-yl)acetate

C21H27NO11 (469.1584)

(4-Methoxybenzyl)thiocarbamic acid 4-O-(tri-O-acetyl-alpha-L-rhamnopyranoside)

C21H27NO9S (469.1406)

2-deoxycytidine-thymidine dimer

C19H27N5O9 (469.1809)

A nucleoside analogue obtained by formal cyclodimerisation of 2-deoxycytidine and thymidine.

LPS 11:3;O3

C17H28NO12P (469.1349)

LPS 12:2;O2

C18H32NO11P (469.1713)

ST 19:5;O6;Tau

C21H27NO9S (469.1406)

ST 20:4;O5;Tau

C22H31NO8S (469.177)

Inauhzin

C25H19N5OS2 (469.1031)

Inauhzin is a dual SirT1/IMPDH2 inhibitor, and acts as an activator p53, used in the research of cancer.

(2s,3r,4s)-4-{[(2r,3s,5s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h,3h,4h,4ah,9h-[1,3]dioxolo[4,5-j]phenanthridine-2,3,6,7-tetrol

C20H23NO12 (469.122)

(3s,4r,5s)-3,4-dihydroxy-5-[(1s)-2-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl]-3-(1h-indol-3-ylmethyl)oxolan-2-one

C21H27NO11 (469.1584)

10-Formylfolic acid

(2S)-2-[[4-[(2-amino-4-oxo-3H-pteridin-6-yl)methyl-formylamino]benzoyl]amino]pentanedioic acid

C20H19N7O7 (469.1346)

4,5-bis(acetyloxy)-6-[4-({[methoxy(sulfanyl)methylidene]amino}methyl)phenoxy]-2-methyloxan-3-yl acetate

C21H27NO9S (469.1406)

17-hydroxy-11-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene-9,10-dione

C23H19NO10 (469.1009)

4-[({10-amino-10-benzyl-7,9,10a-trihydroxy-3-oxo-1h,2h,5h-pyrrolo[1,2-b]isoquinolin-5-yl}(hydroxy)methylidene)amino]butanoic acid

C24H27N3O7 (469.1849)

(7s,9r)-12-bromo-6-hydroxy-4-(3h-imidazol-4-ylmethyl)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C22H24BrN5O2 (469.1113)

2-[3-hexanoyl-9a-methyl-2,9-dioxo-6-(prop-1-en-1-yl)furo[3,2-g]isoquinolin-7-yl]butanedioic acid

C25H27NO8 (469.1737)

(3s)-3-{[(2s,5s,6r)-5-amino-6-methyloxan-2-yl]oxy}-4-(1,5-dihydroxy-9,10-dioxoanthracen-2-yl)-3-methylbutanoic acid

C25H27NO8 (469.1737)

17-hydroxy-11-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene-9,10-dione

C23H19NO10 (469.1009)

3,4-dihydroxy-5-(2-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)-3-(1h-indol-3-ylmethyl)oxolan-2-one

C21H27NO11 (469.1584)

(1'r,3'r,15'r,28's)-3'-hydroxy-27'-methyl-10',13',17',25',27'-pentaazaspiro[cyclopropane-1,12'-heptacyclo[13.10.2.1³,¹⁰.0⁴,⁹.0¹⁶,²⁵.0¹⁸,²³.0¹³,²⁸]octacosane]-4',6',8',16',18',20',22'-heptaene-11',24',26'-trione

(1'r,3'r,15'r,28's)-3'-hydroxy-27'-methyl-10',13',17',25',27'-pentaazaspiro[cyclopropane-1,12'-heptacyclo[13.10.2.1³,¹⁰.0⁴,⁹.0¹⁶,²⁵.0¹⁸,²³.0¹³,²⁸]octacosane]-4',6',8',16',18',20',22'-heptaene-11',24',26'-trione

C26H23N5O4 (469.175)

(2s,3r,4s,4ar)-4-{[(2r,3s,4r,5r,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-2h,3h,4h,4ah,9h-[1,3]dioxolo[4,5-j]phenanthridine-2,3,6,7-tetrol

C20H23NO12 (469.122)

4-(5,7-dihydroxy-2-methyl-4-oxochromen-8-yl)-1-methylpiperidin-3-yl 3,4-dimethoxybenzoate

C25H27NO8 (469.1737)

3'-hydroxy-27'-methyl-10',13',17',25',27'-pentaazaspiro[cyclopropane-1,12'-heptacyclo[13.10.2.1³,¹⁰.0⁴,⁹.0¹⁶,²⁵.0¹⁸,²³.0¹³,²⁸]octacosane]-4',6',8',16',18',20',22'-heptaene-11',24',26'-trione

3'-hydroxy-27'-methyl-10',13',17',25',27'-pentaazaspiro[cyclopropane-1,12'-heptacyclo[13.10.2.1³,¹⁰.0⁴,⁹.0¹⁶,²⁵.0¹⁸,²³.0¹³,²⁸]octacosane]-4',6',8',16',18',20',22'-heptaene-11',24',26'-trione

C26H23N5O4 (469.175)

(2r,3r,4s,4ar)-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h,3h,4h,4ah,9h-[1,3]dioxolo[4,5-j]phenanthridine-3,4,6,7-tetrol

C20H23NO12 (469.122)

(2s,3s,4r,5r,6s)-4,5-bis(acetyloxy)-6-[4-({[methoxy(sulfanyl)methylidene]amino}methyl)phenoxy]-2-methyloxan-3-yl acetate

C21H27NO9S (469.1406)

2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h,3h,4h,4ah,9h-[1,3]dioxolo[4,5-j]phenanthridine-3,4,6,7-tetrol

C20H23NO12 (469.122)

(2s,3s,4r,5s,6r)-5-methoxy-6-methyl-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),17,20(27),21(26),22,24-decaene-3,4,18-triol

(2s,3s,4r,5s,6r)-5-methoxy-6-methyl-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),17,20(27),21(26),22,24-decaene-3,4,18-triol

C27H23N3O5 (469.1638)

12-bromo-6-hydroxy-4-(3h-imidazol-4-ylmethyl)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C22H24BrN5O2 (469.1113)